Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated meta-analysis of randomized controlled trials.

ABSTRACT:

SUBMITTER: Muhammad Daniyal S 

PROVIDER: S-EPMC12837365 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature